[Evaluation of serum aluminum level before and after [DFO] test in patients of hemodialysis unit of Zahedan]

ABSTRACT

Background: aluminum accumulation in plasma and tissues is a well-described complication among persons undergoing peritoneal dialysis or hemodialysis. Excess bone aluminum is associated with low bone formation rates and increased risk for fractures. Current recommendations for care of patients with end-stage renal disease include screening for aluminum toxicity with plasma aluminum levels; patients with levels below20 micro g/L are considered to be at low risk for aluminum related bone disease [ARBD]. By attention to some clinical symptoms that maybe related to AL toxicity, we measured serum AL level before and after DFO test